Research in Diabetic Retinopathy
Several studies in diabetic retinopathy are underway at Mass. Eye and Ear. Here are a few examples of such research.
Eli Lilly Study - Open Label Treatment for Patients Completing Study B7A-MC-MBCM (Protein Kinase C β Inhibitor - Diabetic Retinopathy Study 2 - A Phase 3 Clinical Trial). Lilly Protocol # B7A-MC-MBDV – enrollment closed
ALLERGAN Study - A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS Applicator System) in the Treatment of Patients with Diabetic Macular Edema. Allergan Protocol 206207-011 – enrollment open
GENENTECH Study - A Phase III, Double–Masked, Multicenter, Randomized, Sham-Controlled Study of the Efficacy and Safety of Ranibizumab Injections in Subjects with Clinically Significant Macular Edema with Central Involvement Secondary to Diabetes Mellitus. Genentech Protocol FVF4170g – enrollment open